QNCX
Quince Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$0.11
+0.00 +0.00%
🌙 3월 13일 7:59 PM ET (한국 3/14 08:59)
$0.11
+0.00 -1.41%
| Index | - | P/E | - | EPS (ttm) | -1.22 | Insider Own | 13.18% | Shs Outstand | 0.05B | Perf Week | 4.11% |
| Market Cap | 0.01B | Forward P/E | - | EPS next Y | 37.55% | Insider Trans | -0.68% | Shs Float | 0.05B | Perf Month | -82.54% |
| Enterprise Value | -0.00B | PEG | - | EPS next Q | -0.18 | Inst Own | 46.2% | Short Float | 17.17% | Perf Quarter | -97.33% |
| Income | -0.06B | P/S | - | EPS this Y | 16.47% | Inst Trans | 24.36% | Short Ratio | 0.13 | Perf Half Y | -93.26% |
| Sales | 0.00B | P/B | 5.48 | EPS next 5Y | 47.53% | ROA | -48.2% | Short Interest | 8.30M | Perf YTD | -96.82% |
| Book/sh | 0.02 | P/C | 0.23 | EPS past 3/5Y | 24.29% 7.53% | ROE | -247.78% | 52W High | -97.66% ($4.55) | Perf Year | -92.45% |
| Cash/sh | 0.47 | P/FCF | - | Sales past 3/5Y | - | ROIC | -4018.27% | 52W Low | 21.02% ($0.09) | Perf 3Y | -88.3% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 2.26% | Gross Margin | - | Volatility(W/M) | 11.14% 22.1% | Perf 5Y | -99.73% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.09 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 1.12 | EPS Q/Q | -95.91% | Profit Margin | - | RSI (14) | 28.21 | Recom | 3.4 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.12 | Sales Q/Q | - | SMA20 | -17.74% ($0.13) | Beta | 1.31 | Target Price | $5.5 |
| Payout | - | Debt/Eq | 16.97 | Earnings | 11000000 | SMA50 | -91.6% ($1.31) | Rel Volume | 0.25 | Prev Close | $0.11 |
| Employees | 36 | LT Debt/Eq | 0.34 | EPS/Sales Surpr. | -16.28% - | SMA200 | -94.03% ($1.84) | Avg Volume(3M) | 64.84M | Price | $0.11 |
| IPO | 2019/5/9 | Option/Short | Yes/Yes | Trades | 5504 | Volume | 16,295,700 | Change | - |
뉴스 로딩 중...